[1]

HAO Ji-qing, SUN Gen-yun, SHEN Yu-xian. Mechanisms of lumiracoxib on apoptosis in human lung cancer cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(1): 47-51.

[2]

PU Qi-song, LEI Jun, HANG Xiang. Effects of aspirin-niacinamide-zinc complex (WUY) on platelet aggrega-tion and experimental thrombosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(5): 574-578.

[3]

CHAI Yi, DING Jian-hua, LI Hao, HU Gang. Effects of iptakalim hydrochloride on H₂O₂ induced cytotoxicity in pheochromocytoma(PC12) cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 377-381.

[4]

BAI Xia, MA Yu-dong, MU Hong, FAN Shu-duo. Effects of chuanhuning injection on contents of PGE₂ and cAMP in hypothalamus in fever rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 75-78.

[5]

PU Qi-Song, LEI Jun, ZHANG Xiang. Experimental studies on analgesic and anti-inflammation effects of aspirinniacinamide-zinc complex (WUY) [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(12): 1420-1423.

[6]

GAO Xue-Qin, HAN Jin-Xiang, ZHANG Wei-Dong, SONG Shou-Qin, ZHU Bo. Effects of aspirin and sulindac on expression of cyclooxygenase-2, vascular endothelial growth factor, laminin receptor, and CD₄₄V₆ in 3AO cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 906-910.

[7]

GUO Wei, CUI Jing-Rong. Does selection of combination treatment of cisplatin and cyclophosphamide [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(7): 744-746.

[8]

HU Ai-Ping, HU Guo-Xin, QIU Xiang-Jun, DAI Zong-Shun. Study of pharmacokinetics of diclofenac sodium sustained-released suppository in Chinese healthy volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 451-454.

[9]

ZHANG Yan-Ling, YE Chun-Ling, lU Yan-Qing, YE Kai-He, lU Jun-Hua, lIU Jian-Jun. Effects of diclofenac onProliferation inleukemia K562 cells and synergism with adriomycin [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 408-410.

[10]

SU Yuan-Qi, DONG Zhi. Progress of cyclooxygense-2 inhibitors in treatment of Alzheimer' s disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 249-251.

[11]

HU Guo-Xin, QIU Xiang-Jun, XIE Hong, DAI Zong-Shun, WANG Gui-Zhen. Pharmacokinetics and bioequivalance of aceclofenac enter-coated tablets in healthy male volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 329-332.

[12]

LI Xiao-Mei, LI Xiang-Pei, WANG Guo-Sheng, SHAN Shu-Guang, QIAN Long. Effectiveness and safety of actarit in the treatment of patients with active rheumatoid arthritis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(2): 189-191.

[13]

ZHA Zhen-Zhong, WANG Hui, FENG Xiao-Long, XU Wei-Ming. Comparison of the effect of azone and menthol on the percutaneous ab-sorption of indomethacin in vitro [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(1): 27-29.

[14]

LIU Hui-Fen, XIE Xiao-Hu, ZHOU Wen-Hua, YANG Guo-Dong. Expression ofμandκopiate receptor in spinal cord and brainstem during morphine withdrawal in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(1): 1-5.

[15]

. [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(1): 73-75.

PDF (PC)

Knowledge